Clinical Trial

Endometrial Cancer Vaginal Fluid Specimen Collection Study

Study acronym: ENVISION
Recruiting
View on ClinicalTrials.gov →
Summary
This is a multicenter, prospective, specimen collection study for development and evaluation of tests used to detect endometrial cancer, other cancers, or their causes.
Protocol Amendment History 1 change
notable Trial sites expanded: 1 -> 4 locations 2026-08-04
Trial Details
NCT Number NCT07544680
Lead Sponsor Exact Sciences Corporation
Conditions Abnormal Uterine Bleeding (AUB), Endometrial Cancer, Atypical Endometrial Hyperplasia, Endometrial Hyperplasia With Atypia, Endometrial Intraepithelial Neoplasia
Enrollment 4,200 participants
Start Date 2026-03-10
Primary Completion 2028-04-24 (estimated)
Study Completion 2028-04-24 (estimated)
Updated on ClinicalTrials.gov 2026-08-03